Content
Chemoradiotherapy helped a patient with cervical cancer and metastases to the paracaval and right iliac lymph nodes.
Patient N., 61 years old. In January 2015, when discharge from the genital tract appeared. Cytogram of a cervical smear: squamous cell carcinoma. I contacted EMC for further examination and treatment.
PET/CT scan from 05/27/2015 (before treatment)
Metastases to the paracaval and right iliac lymph nodes were revealed. The patient was referred by a gynecologist to consult an oncologist-radiotherapist to resolve the issue of radiation therapy.
MRI of the pelvic organs dated 05/22/2015: the cervix was transformed into a tissue neoplasm with central necrosis in size; the formation performs the vaginal and supravaginal parts of the cervix, extends to the right parametrium; the presence of superficial infiltration of the utero-vesicular tissue cannot be excluded; an enlarged lymph node of the right external iliac group is visualized; other pelvic lymph nodes of normal size and structure, with clear contours; paraaortic lymphadenopathy was not detected.
Consultation of a radiotherapist oncologist dated 05/21/2015: A patient has cervical cancer with metastases to the paracaval and right iliac lymph nodes cT2bN1M1, stage IV. Competitive chemoradiotherapy according to a radical program with weekly cisplatin administration is recommended.
On 24.06.2015, CT simulation was performed on a Briliance big Bore Phillips X-ray tomograph. From 06/29/2015 to 08/14/2015, a course of radiation therapy was conducted at the TrueBeam linear accelerator using the RapidArc photon technique. Cisplatin was administered weekly intravenously.
Control PET/CT scan on 08/12/2018 (after treatment)
There is no evidence for the presence of foci of pathological metabolic activity characteristic of the 18F-FDG positive neoplastic process.
.webp)
